Fennec Pharmaceuticals Stock Price History
FENC Stock | USD 7.58 0.54 7.67% |
Below is the normalized historical share price chart for Fennec Pharmaceuticals extending back to November 12, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Fennec Pharmaceuticals stands at 7.58, as last reported on the 20th of May, with the highest price reaching 7.58 and the lowest price hitting 6.70 during the day.
If you're considering investing in Fennec Stock, it is important to understand the factors that can impact its price. Fennec Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0626, which denotes the company had a -0.0626% return per unit of risk over the last 3 months. Fennec Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Fennec Pharmaceuticals' Standard Deviation of 4.05, variance of 16.42, and Mean Deviation of 2.1 to check the risk estimate we provide.
At present, Fennec Pharmaceuticals' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 5.6 M, whereas Total Stockholder Equity is projected to grow to (11 M). . The current year's Price Earnings To Growth Ratio is expected to grow to 0.54, whereas Price To Sales Ratio is forecasted to decline to 13.09. Fennec Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of June 2001 | 200 Day MA 8.9639 | 50 Day MA 9.8417 | Beta 0.456 |
Fennec |
Sharpe Ratio = -0.0626
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | FENC |
Estimated Market Risk
4.11 actual daily | 36 64% of assets are more volatile |
Expected Return
-0.26 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Fennec Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fennec Pharmaceuticals by adding Fennec Pharmaceuticals to a well-diversified portfolio.
Price Book 84.8176 | Enterprise Value Ebitda (11.05) | Price Sales 12.1601 | Shares Float 15.4 M | Wall Street Target Price 16.83 |
Fennec Pharmaceuticals Stock Price History Chart
There are several ways to analyze Fennec Stock price data. The simplest method is using a basic Fennec candlestick price chart, which shows Fennec Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | March 28, 2024 | 11.12 |
Lowest Price | May 15, 2024 | 6.98 |
Fennec Pharmaceuticals May 20, 2024 Stock Price Synopsis
Various analyses of Fennec Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Fennec Stock. It can be used to describe the percentage change in the price of Fennec Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Fennec Stock.Fennec Pharmaceuticals Price Action Indicator | 0.71 | |
Fennec Pharmaceuticals Price Rate Of Daily Change | 1.08 | |
Fennec Pharmaceuticals Price Daily Balance Of Power | 0.61 |
Fennec Pharmaceuticals May 20, 2024 Stock Price Analysis
Fennec Stock Price History Data
The price series of Fennec Pharmaceuticals for the period between Tue, Feb 20, 2024 and Mon, May 20, 2024 has a statistical range of 4.14 with a coefficient of variation of 10.16. Under current investment horizon, the daily prices are spread out with arithmetic mean of 9.71. The median price for the last 90 days is 9.61. The company completed 1:3 stock split on 5th of September 2014.Open | High | Low | Close | Volume | ||
05/20/2024 | 7.04 | 7.58 | 6.70 | 7.58 | ||
05/20/2024 | 7.04 | 7.58 | 6.70 | 7.58 | ||
05/17/2024 | 7.03 | 7.09 | 6.70 | 7.04 | 306,769 | |
05/16/2024 | 7.14 | 7.19 | 6.66 | 7.12 | 361,905 | |
05/15/2024 | 7.83 | 7.88 | 6.78 | 6.98 | 780,522 | |
05/14/2024 | 9.02 | 9.27 | 6.51 | 7.34 | 1,105,061 | |
05/13/2024 | 9.88 | 10.07 | 9.80 | 10.02 | 127,504 | |
05/10/2024 | 9.41 | 9.83 | 9.40 | 9.75 | 102,221 | |
05/09/2024 | 9.10 | 9.46 | 9.10 | 9.42 | 43,646 | |
05/08/2024 | 9.25 | 9.45 | 9.19 | 9.27 | 38,946 | |
05/07/2024 | 9.19 | 9.40 | 9.08 | 9.35 | 54,392 | |
05/06/2024 | 9.26 | 9.29 | 9.05 | 9.09 | 88,712 | |
05/03/2024 | 9.23 | 9.38 | 9.15 | 9.23 | 71,279 | |
05/02/2024 | 9.21 | 9.31 | 8.94 | 9.09 | 94,511 | |
05/01/2024 | 9.20 | 9.31 | 8.99 | 9.09 | 73,580 | |
04/30/2024 | 9.05 | 9.32 | 9.01 | 9.18 | 89,690 | |
04/29/2024 | 9.40 | 9.40 | 9.05 | 9.14 | 49,334 | |
04/26/2024 | 9.15 | 9.30 | 9.04 | 9.21 | 154,291 | |
04/25/2024 | 9.00 | 9.33 | 8.83 | 9.16 | 120,030 | |
04/24/2024 | 9.18 | 9.30 | 8.95 | 9.07 | 182,107 | |
04/23/2024 | 9.50 | 9.61 | 9.05 | 9.24 | 288,706 | |
04/22/2024 | 9.34 | 9.49 | 9.15 | 9.38 | 165,455 | |
04/19/2024 | 9.52 | 9.65 | 9.18 | 9.34 | 143,207 | |
04/18/2024 | 9.60 | 9.85 | 9.46 | 9.57 | 159,643 | |
04/17/2024 | 10.26 | 10.29 | 9.70 | 9.70 | 249,137 | |
04/16/2024 | 10.21 | 10.52 | 10.06 | 10.26 | 103,709 | |
04/15/2024 | 10.45 | 10.58 | 10.13 | 10.33 | 123,448 | |
04/12/2024 | 10.81 | 10.92 | 10.44 | 10.49 | 104,509 | |
04/11/2024 | 10.72 | 11.11 | 10.58 | 10.83 | 58,660 | |
04/10/2024 | 10.70 | 10.82 | 10.53 | 10.67 | 93,505 | |
04/09/2024 | 10.73 | 10.91 | 10.38 | 10.89 | 130,046 | |
04/08/2024 | 10.46 | 11.02 | 10.46 | 10.83 | 43,680 | |
04/05/2024 | 10.86 | 11.07 | 10.65 | 10.69 | 103,807 | |
04/04/2024 | 10.91 | 11.15 | 10.71 | 10.91 | 166,666 | |
04/03/2024 | 10.89 | 10.96 | 10.73 | 10.77 | 114,772 | |
04/02/2024 | 10.75 | 11.29 | 10.69 | 10.99 | 222,671 | |
04/01/2024 | 11.05 | 11.16 | 10.75 | 10.84 | 111,221 | |
03/28/2024 | 11.20 | 11.37 | 11.04 | 11.12 | 120,083 | |
03/27/2024 | 11.04 | 11.15 | 10.98 | 11.09 | 102,037 | |
03/26/2024 | 10.97 | 11.15 | 10.78 | 10.89 | 122,955 | |
03/25/2024 | 10.75 | 11.27 | 10.75 | 11.00 | 206,484 | |
03/22/2024 | 11.16 | 11.47 | 10.75 | 10.80 | 175,183 | |
03/21/2024 | 11.39 | 11.49 | 10.83 | 11.07 | 290,999 | |
03/20/2024 | 10.94 | 11.29 | 10.86 | 11.07 | 146,209 | |
03/19/2024 | 10.91 | 11.25 | 10.62 | 11.01 | 257,856 | |
03/18/2024 | 10.75 | 11.43 | 10.63 | 11.07 | 447,257 | |
03/15/2024 | 9.92 | 10.02 | 9.65 | 9.94 | 289,937 | |
03/14/2024 | 9.90 | 10.12 | 9.74 | 10.00 | 102,086 | |
03/13/2024 | 9.66 | 9.90 | 9.63 | 9.90 | 61,707 | |
03/12/2024 | 9.40 | 9.75 | 9.40 | 9.72 | 137,489 | |
03/11/2024 | 9.74 | 9.79 | 9.43 | 9.47 | 98,972 | |
03/08/2024 | 9.60 | 10.03 | 9.50 | 9.66 | 101,687 | |
03/07/2024 | 9.79 | 9.85 | 9.53 | 9.61 | 117,824 | |
03/06/2024 | 9.69 | 9.93 | 9.50 | 9.79 | 122,900 | |
03/05/2024 | 9.80 | 9.88 | 9.50 | 9.57 | 87,853 | |
03/04/2024 | 9.84 | 9.96 | 9.70 | 9.77 | 65,195 | |
03/01/2024 | 9.50 | 9.92 | 9.44 | 9.82 | 75,828 | |
02/29/2024 | 9.49 | 9.99 | 9.32 | 9.47 | 328,804 | |
02/28/2024 | 9.26 | 9.50 | 9.26 | 9.31 | 110,859 | |
02/27/2024 | 9.08 | 9.48 | 9.01 | 9.35 | 104,139 | |
02/26/2024 | 9.00 | 9.23 | 8.98 | 9.14 | 88,866 |
About Fennec Pharmaceuticals Stock history
Fennec Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Fennec is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Fennec Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Fennec Pharmaceuticals stock prices may prove useful in developing a viable investing in Fennec Pharmaceuticals
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 26.6 M | 27.9 M | |
Net Loss | -21.3 M | -20.3 M |
Fennec Pharmaceuticals Quarterly Net Working Capital |
|
Fennec Pharmaceuticals Stock Technical Analysis
Fennec Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Price Exposure Probability Now
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets |
All Next | Launch Module |
Fennec Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Fennec Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Fennec Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Fennec to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.33) | |||
Total Risk Alpha | (0.94) | |||
Treynor Ratio | (2.62) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fennec Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Fennec Stock analysis
When running Fennec Pharmaceuticals' price analysis, check to measure Fennec Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fennec Pharmaceuticals is operating at the current time. Most of Fennec Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Fennec Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fennec Pharmaceuticals' price. Additionally, you may evaluate how the addition of Fennec Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Transaction History View history of all your transactions and understand their impact on performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Fennec Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fennec Pharmaceuticals. If investors know Fennec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fennec Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.04 | Revenue Per Share 1.684 | Quarterly Revenue Growth 14.132 | Return On Assets 0.0857 | Return On Equity (10.06) |
The market value of Fennec Pharmaceuticals is measured differently than its book value, which is the value of Fennec that is recorded on the company's balance sheet. Investors also form their own opinion of Fennec Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Fennec Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fennec Pharmaceuticals' market value can be influenced by many factors that don't directly affect Fennec Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fennec Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.